Influx of extracellular calcium participates in rituximab-enhanced ionizing radiation-induced apoptosis in Raji cells

Toxicology Letters

Volumn 209, Issue 3, 2012, Pages 221-226

  Fengling, Min ^a   Qingxiang, Gao ^a   Lijia, Zhai ^a   Wei, Zhou ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

H2AX foci; Ca 2+ i; Apoptosis; Lymphoma cell line; Rituximab; X ray

Indexed keywords

CALCIUM; DNA; EGTAZIC ACID; HISTONE H2AX; MAGNESIUM; RITUXIMAB;

APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CELL SURVIVAL; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFECT; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; IONIZING RADIATION; KINETICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAJI CELL; X IRRADIATION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; ANTINEOPLASTIC AGENTS; APOPTOSIS; BURKITT LYMPHOMA; CALCIUM; CALCIUM SIGNALING; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; HISTONES; HUMANS;

EID: 84856177953     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.12.018     Document Type: Article

References (33)

1. An J., Huang Y.C., Xu Q.Z., Zhou L.J., Shang Z.F., Huang B., Wang Y., Liu X.D., Wu D.C., Zhou P.K. DNA-PKcs play a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression. BMC Mol. Biol. 2010, 11:18.
2. Boehrer S., Nowak D., Hoelzer D., Mitrou P.S., Chow K.U. Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies. Curr. Pharm. Des. 2006, 12(1):111-128.
3. 2+ conductance found constitutively in B lymphocytes. J. Cell Biol. 1993, 121:1121-1132.
4. Buske C., Weigert O., Dreyling M., Unterhalt M., Hiddemann W. Current status and perspective of antibody therapy in follicular lymphoma. Haematologica 2006, 91(1):104-112.
5. Daniels I., Turzanski J., Haynes A.P. A requirement for calcium in the caspase-independent killing of Burkitt lymphoma cell lines by Rituximab. Br. J. Haematol. 2008, 142(3):394-403.
6. Dearden C.E. Role of antibody therapy in lymphoid malignancies. Br. Med. Bull. 2007, 83:275-290.
7. 2+/calmodulin in the ionizing radiation-induced cell cycle arrest. Mol. Cell. Proteomics 2006, 5:1033-1044.
8. Gupta D., Crosby M.E., Almasan A., Macklis R.M. Regulation of CD20 expression by radiation-induced changes in intracellular redox status. Free Radic. Biol. Med. 2008, 44(6):614-623.
9. Hofmeister J.K., Cooney D., Coggeshall K.M. Clustered CD20 induced apoptosis. src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis. Blood Cells. Mol. Dis. 2000, 26(2):133-143.
10. Ishibashi K., Suzuki M., Sasaki S., Imai M. Identification of a new multigene four-transmembrane family (MS4A) related to CD20, HTm4 and beta subunit of the high-affinity IgE receptor. Gene 2001, 264(1):87-93.
11. Janas E., Priest R., Wilde J.I., White J.H., Malhotra R. Rituxan (anti-CD 20 antibody)-induced translocation of CD 20 into lipid rafts is crucial for calcium influx and apoptosis. Clin. Exp. Immunol. 2005, 139(3):439-446.
12. Juin P., Pelletier M., Oliver L., Tremblais K., Gregoire M., Meflah K., Vallette F.M. Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J. Biol. Chem. 1998, 273(28):17559-17564.
13. Kang J., Ferguson D., Song H., Bassing C., Eckersdorff M., Alt F.W., Xu Y. Functional Interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Mol. Cell Biol. 2005, 25(2):661-670.
14. Kapadia N.S., Engles J.M., Wahl R.L. In vitro evaluation of radioprotective and radiosensitizing effects of rituximab. J. Nucl. Med. 2008, 49(4):674-678.
15. Khan A.A., Soloski M.J., Sharp A.H., Schilling G., Sabatini D.M., Li S.H., Ross C.A., Snyder S.H. Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-triphosphate receptor. Science 1996, 273(5274):503-507.
16. Klokov D., MacPhail S.M., Banáth J.P., Byrne J.P., Olive P.L. Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. Radiother. Oncol. 2006, 80(2):223-229.
17. Li H., Ayer L.M., Lytton J., Deans J.P. Store-operated cation entry mediated by CD20 in membrane rafts. J. Biol. Chem. 2003, 278(43):42427-42434.
18. Löbrich M., Shibata A., Beucher A., Fisher A., Ensminger M., Goodarzi A.A., Barton O., Jeggo P.A. Gamma-H2AX foci analysis for monitoring DNA double-strand break repair. Cell Cycle 2010, 9(4):662-669.
19. Min F.L., Liu F.J., Wen W.X., Zhai L.J., Tong J.D., Wang Z., Yuan X., Gao Q.X. Rituximab sensitizes a Burkitt lymphoma cell line to cell killing by X-irradiation. Radiat. Environ. Biophys. 2009, 48(4):371-378.
20. Mustonen R., Bouvier G., Wolber G., Stöhr M., Peschke P., Bartsch H. A comparison of gamma and neutron irradiation on Raji cells: effects on DNA damage, repair, cell cycle distribution and lethality. Mutat. Res. 1999, 429(2):169-179.
21. Parkash J., Asotra K. Calcium wave signaling in cancer cells. Life Sci. 2010, 87(19-22):587-595.
22. Prishchep S.G., Gerasimovich N.V., Milyutin A.A. The effect of low doses of gamma irradiation on the homeostasis of intracellular calcium in lymphocyte cells of rats?. Radiat. Prot. Dosim. 2002, 99(1-4):173-174.
23. Redon C.E., Dickey J.S., Bonner W.M., Sedelnikova O.A. γ-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skin. Adv. Space Res. 2009, 43(8):1171-1178.
24. Rothkamm K., Horn S. γ-H2AX as protein biomarker for radiation exposure. Ann. Ist. Super. Sanita 2009, 45(3):265-271.
25. Shankar B., Kumar S.S., Sainis K.B. Generation of reactive oxygen species and radiation response in lymphocytes and tumor cells. Radiat. Res. 2003, 160(4):478-487.
26. Skvortsova I., Skvortsov S., Popper B.A., Haidenberger A., Saurer M., Gunkel A.R., Zwierzina H., Lukas P. Rituximab enhances radiation-triggered apoptosis in non-Hodgkin's lymphoma cells via caspase-dependent and -independent mechanisms. J. Radiat. Res. (Tokyo) 2006, 47(2):183-196.
27. Skvortsova I., Popper B.A., Skvortsov S., Saurer M., Auer T., Moser R., Kamleitner H., Zwierzina H., Lukas P. Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells. J. Radiat. Res. (Tokyo) 2005, 46(2):241-248.
28. Takahashi K., Inanami O., Kuwabara M. Effects of intracellular calcium chelator BAPTA-AM on radiation-induced apoptosis regulated by activation of SAPK/JNK and caspase-3 in MOLT-4 cells. Int. J. Radiat. Biol. 1999, 75(9):1099-1105.
29. Unruh T.L., Li H., Mutch C.M., Shariat N., Grigoriou L., Sanyal R., Brown C.B., Deans J.P. Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking. Immunology 2005, 116(2):223-232.
30. 2+ in radiation-induced apoptosis suppresses DNA fragmentation but does not enhance clonogenic survival. Int. J. Radiat. Biol. 1997, 71(3):237-243.
31. Walshe C.A., Beers S.A., French R.R., Chan C.H., Johnson P.W., Packham G.K., Glennie M.J., Cragg M.S. Induction of cytosolic calcium flux by CD20 is dependent upon B cell antigen receptor signaling. J. Biol. Chem. 2008, 283(25):16971-16984.
32. Warters R.L., Adamson P.J., Pond C.D., Leachman S.A. Melanoma cells express elevated levels of phosphorylated histone H2AX foci. J. Invest. Dermatol. 2005, 124(4):807-817.
33. Yoshikawa T., Kashino G., Ono K., Watanabe M. Phosphorylated H2AX foci in tumor cells have no correlation with their radiation sensitivities. J. Radiat. Res. (Tokyo) 2009, 50(2):151-160.